🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open-label, controlled, randomised, multi-centre Phase 3 trial evaluatin...
Status
Terminated
Location
UCLA Medical Center Plaza
Start Date
2022-12-22
Trial ID
NCT05679401
Treatments Being Tested
The goal of this follow-up study is to learn about long-term patient surviv...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham (UAB) Hospital
Start Date
2023-04-21
Trial ID
NCT05714514
An open-label, controlled, randomized Phase 3 trial evaluating 12-month kid...
Status
Completed
Location
University of Alabama at Birmingham (UAB) Hospital
Start Date
2021-10-14
Trial ID
NCT04935177
Treatments Being Tested
This study will evaluate the safety and tolerability of IdeS in patients wi...
Status
Completed
Location
Department of Internal Medicine IV (Nephrology and Hypertension)
Start Date
2017-06-16
Trial ID
NCT03157037
Treatments Being Tested
A prospective, post-authorisation long-term follow-up trial of patients pre...
Status
Active Not Recruiting
Location
Medizinische Universitaet Wien
Start Date
2023-07-03
Trial ID
NCT05937750
The aim of this trial is to collect data and provide a better understanding...
Status
Terminated
Location
Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie MUW
Start Date
2021-01-20
Trial ID
NCT04711850
Treatments Being Tested
Imlifidase is a recombinant cysteine protease derived from Streptococcus py...
Status
Not Yet Recruiting
Location
CHU Amiens Picardie Site Sud
Start Date
2026-01
Trial ID
NCT07379957
The main purpose of this study is to evaluate safety and tolerability in pa...
Status
Terminated
Location
University College London Hospitals NHS
Start Date
2016-09
Trial ID
NCT02854059
Treatments Being Tested
An open-label post authorization efficacy and safety study evaluating graft...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2022-04-19
Trial ID
NCT05369975
Treatments Being Tested
Clinical trial rationale: CNS is an ultra-rare (\<1/1 million newborns), a...
Status
Recruiting
Location
Hopital Antoine BECLERE
Start Date
2024-11-08
Trial ID
NCT06518005
Treatments Being Tested